A Clinical Case Report of Deficiency of Adenosine Deaminase 2 Syndrome (DADA 2) Presenting as a Brachial Artery Aneurysm.

Q4 Medicine
Mediterranean Journal of Rheumatology Pub Date : 2025-10-23 eCollection Date: 2025-03-01 DOI:10.31138/mjr.120324.dai
Shama Sowdagar, Avanish Jha, Prabhu Vasanth, John Mathew
{"title":"A Clinical Case Report of Deficiency of Adenosine Deaminase 2 Syndrome (DADA 2) Presenting as a Brachial Artery Aneurysm.","authors":"Shama Sowdagar, Avanish Jha, Prabhu Vasanth, John Mathew","doi":"10.31138/mjr.120324.dai","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Deficiency of adenosine deaminase 2 (DADA 2) syndrome is a monogenic auto-inflammatory vasculitic syndrome caused by loss of function mutations in the ADA2 gene. Disease manifestations are divided into three major phenotypes: inflammatory/vascular, immune dysregulation, and haematologic, with majority having significant overlap between these phenotypes. The disease has undergone extensive phenotypic expansion since its first description in 2014. It is autosomal recessively inherited and commonly presents with fever, recurrent strokes, livedo racemosa, and polyarteritis nodosa (PAN)-like features. Though the disease has its symptom onset early in childhood, various case series have described patients with symptom onset in adulthood. Visceral arterial aneurysms as a manifestation have been described in literature but not peripheral aneurysms. Here, we describe a young adult with DADA 2 syndrome presenting with peripheral arterial aneurysm involving the brachial artery.</p><p><strong>Case report: </strong>Patient had recurrent episodes of CVA since childhood, a history of orchitis, systemic hypertension, and new onset brachial artery aneurysm at the age of twenty-three. Diagnosis was confirmed by genetic analysis. Tumour necrosis factor inhibitors (TNFi) have emerged as the drug of choice for the treatment of DADA2 and studies revealed a drastic reduction in stroke risk after initiation of TNFi. Based on this experience, we have started the patient on adalimumab, and he is doing well for the past one year.</p><p><strong>Conclusion: </strong>Peripheral artery aneurysm can be a manifestation of vasculitis in DADA 2 syndrome.</p>","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"36 1","pages":"136-139"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183452/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediterranean Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31138/mjr.120324.dai","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Deficiency of adenosine deaminase 2 (DADA 2) syndrome is a monogenic auto-inflammatory vasculitic syndrome caused by loss of function mutations in the ADA2 gene. Disease manifestations are divided into three major phenotypes: inflammatory/vascular, immune dysregulation, and haematologic, with majority having significant overlap between these phenotypes. The disease has undergone extensive phenotypic expansion since its first description in 2014. It is autosomal recessively inherited and commonly presents with fever, recurrent strokes, livedo racemosa, and polyarteritis nodosa (PAN)-like features. Though the disease has its symptom onset early in childhood, various case series have described patients with symptom onset in adulthood. Visceral arterial aneurysms as a manifestation have been described in literature but not peripheral aneurysms. Here, we describe a young adult with DADA 2 syndrome presenting with peripheral arterial aneurysm involving the brachial artery.

Case report: Patient had recurrent episodes of CVA since childhood, a history of orchitis, systemic hypertension, and new onset brachial artery aneurysm at the age of twenty-three. Diagnosis was confirmed by genetic analysis. Tumour necrosis factor inhibitors (TNFi) have emerged as the drug of choice for the treatment of DADA2 and studies revealed a drastic reduction in stroke risk after initiation of TNFi. Based on this experience, we have started the patient on adalimumab, and he is doing well for the past one year.

Conclusion: Peripheral artery aneurysm can be a manifestation of vasculitis in DADA 2 syndrome.

Abstract Image

以臂动脉瘤表现的腺苷脱氨酶2缺乏综合征(DADA 2) 1例临床报告。
简介:腺苷脱氨酶2缺乏症(DADA 2)是一种由ADA2基因功能突变丧失引起的单基因自身炎症性血管综合征。疾病表现分为三种主要表型:炎症/血管、免疫失调和血液学,大多数在这些表型之间有明显的重叠。自2014年首次描述以来,该疾病经历了广泛的表型扩展。它是常染色体隐性遗传的,通常表现为发烧,反复中风,活的总状瘤和结节性多动脉炎(PAN)样特征。虽然该病的症状出现在儿童早期,但各种病例系列都描述了成年期出现症状的患者。内脏动脉动脉瘤作为一种表现已经在文献中被描述过,但没有被描述过周围动脉瘤。在这里,我们描述了一个年轻的成年人与DADA 2综合征表现为外周动脉动脉瘤累及肱动脉。病例报告:患者自幼反复发作CVA,有睾丸炎、全身性高血压病史,23岁时新发肱动脉瘤。经遗传分析确诊。肿瘤坏死因子抑制剂(TNFi)已成为治疗DADA2的首选药物,研究表明,开始使用TNFi后,卒中风险急剧降低。基于这一经验,我们开始给患者使用阿达木单抗,他在过去的一年里表现良好。结论:外周动脉瘤可能是DADA 2综合征血管炎的一种表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
42
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信